TOBIRA THERAPEUTICS INC's ticker is TBRA and the CUSIP is 88883P101. A total of 50 filers reported holding TOBIRA THERAPEUTICS INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $9,654,000 | +126.6% | 242,940 | -28.4% | 0.00% | – |
| Q2 2016 | $4,260,000 | +62.7% | 339,175 | +6.0% | 0.00% | – |
| Q1 2016 | $2,618,000 | -17.3% | 320,050 | +1.6% | 0.00% | – |
| Q4 2015 | $3,167,000 | +6.6% | 315,144 | +2.5% | 0.00% | – |
| Q3 2015 | $2,970,000 | -34.2% | 307,435 | +17.6% | 0.00% | – |
| Q2 2015 | $4,511,000 | – | 261,493 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 2,668,570 | $33,517,000 | 26.73% |
| Stonepine Capital Management, LLC | 637,567 | $8,008,000 | 8.21% |
| Abingworth LLP | 589,244 | $7,377,000 | 7.72% |
| BVF INC/IL | 1,253,401 | $15,743,000 | 3.35% |
| Novo Holdings A/S | 2,027,091 | $25,460,000 | 2.67% |
| NEXTHERA CAPITAL LP | 75,000 | $942,000 | 0.82% |
| BB BIOTECH AG | 468,000 | $5,878,000 | 0.23% |
| TFS CAPITAL LLC | 42,404 | $533,000 | 0.10% |
| EverPoint Asset Management, LLC | 150,000 | $1,884,000 | 0.04% |
| MARSHALL WACE, LLP | 168,769 | $2,120,000 | 0.02% |